共 50 条
Peroxisome Proliferator-Activated Receptor γ Antagonists Decrease Na+ Transport via the Epithelial Na+ Channel
被引:24
|作者:
Pavlov, Tengis S.
[1
]
Levchenko, Vladislav
[1
]
Karpushev, Alexey V.
[1
]
Vandewalle, Alain
[3
]
Staruschenko, Alexander
[1
,2
]
机构:
[1] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Kidney Dis Ctr, Milwaukee, WI 53226 USA
[3] Univ Paris, INSERM, U773, Ctr Rech Biomed Bichat Beaujon, F-75252 Paris, France
关键词:
INDUCED FLUID RETENTION;
INDUCIBLE KINASE SGK1;
DUCT PRINCIPAL CELLS;
PPAR-GAMMA;
SODIUM-CHANNEL;
PLASMA-MEMBRANE;
BLOOD-PRESSURE;
ENAC ACTIVITY;
UP-REGULATION;
ALPHA-ENAC;
D O I:
10.1124/mol.109.056911
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
The epithelial sodium channel (ENaC) is believed to represent the rate-limiting step for sodium absorption in the renal collecting duct. Consequently, ENaC is a central effector affecting systemic blood volume and pressure. Sodium and water transport are dysregulated in diabetes mellitus. Peroxisome proliferator-activated receptor gamma (PPAR gamma) agonists are currently used in the treatment of type 2 diabetes, although their use remains limited by fluid retention. The effects of PPAR gamma agonists on ENaC activity remain controversial. Although PPAR gamma agonists were shown to stimulate ENaC-mediated renal salt absorption, probably via the serum-and glucocorticoid-regulated kinase 1, other studies reported that the PPAR gamma agonist-induced fluid retention is independent of ENaC activity. Here we confirmed that four chemically distinct PPAR gamma agonists [pioglitazone, rosiglitazone, troglitazone, and 15-deoxy-Delta(12,14)-prostaglandin J(2) (PGJ(2))] do not enhance Na+ transport in cultured renal collecting duct principal mpkCCD(c14) cells, as assessed by short-circuit current measurements. However, the PPAR gamma antagonist 2-chloro-5-nitro-N-4-pyridinyl-benzamide (T0070907), and to a lesser extent 2-chloro-5-nitrobenzanilide (GW9662), were found to decrease Na+ reabsorption across mpkCCD(c14) cell layers. Furthermore, pretreatment of monolayers with T0070907 diminished the insulin-stimulated sodium transport. PPAR gamma agonist PGJ(2) did not enhance insulin-stimulated Na+ flux via ENaC. We also show that PPAR gamma enhances ENaC activity when all three subunits are reconstituted in Chinese hamster ovary (CHO) cells. GW9662 inhibits ENaC activity when ENaC subunits are coexpressed in CHO cells with PPAR gamma. In contrast, rosiglitazone has no effect on ENaC activity. We conclude that PPAR gamma activity is important for maintaining basal and insulin-dependent transepithelial Na+ transport and ENaC activity.
引用
收藏
页码:1333 / 1340
页数:8
相关论文